4.4 SURPASS-4 trial comparison of tirzepatide and insulin glargine The SURPASS-4 trial included 1,995 patients with type 2 diabetes and compared tirzepatide (5 mg, 10 mg, 15 mg) with insulin glargine over 52 weeks, with the primary endpoint being the change in HbA1c (Heerspink et al., 2022)
Patients need to carefully research options to make sure theyre getting high-quality care
PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) with a flat monthly price regardless of dose levelyour dose may need to go up, but your price won't
Overall, I am still learning a lot about GLP-1s, but I can safely say that I dont think theyre cheating
Combining fasting with GLP-1 weight loss treatments can be a powerful strategy to accelerate weight loss, improve metabolic health, and achieve your goals
Sterile Syringe: An insulin syringe (typically 1mL/100 units) is perfect for accurate measurement